DBVTSMALL

DBV Technologies S.A.

HealthcareBiotechnology
$16.01
$0.00(-0.06%)
52W$8.51
$26.18
Updated Jun 29, 02:00 AM
RSI40
RS Rating22/99
Beta1.11
Volatility77%
F-Score4/9
Mkt Cap$948M
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

DBV Technologies S.A. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 22), showing significant lag compared to the market leaders. Earnings growth of 92% provides fundamental context to the price action. Investors should exercise caution due to high volatility (77% annualized), which requires wider risk management.

Relative Strength
22
out of 99
Lagging
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
1.11
vs S&P 500
ABOVE MKT
52W Position
42%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$18.53
50 SMA > 100 SMA$19.88
100 SMA > 150 SMA$19.35
150 SMA > 200 SMA$17.78

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$16.81-4.74%BELOW
50 SMA$18.53-13.61%BELOW
100 SMA$19.88-19.46%BELOW
150 SMA$19.35-17.25%BELOW
200 SMA$17.78-9.94%BELOW

Price Performance

1D-0.1%
1W+2.0%
1M-11.8%
3M-20.8%
6M-16.5%
YTD-16.0%
1Y+73.8%
3Y-7.3%
52-Week Trading Range42% from low
$16.01
52W Low$8.51
52W High$26.18

Technical Indicators

RSI (14)NEUTRAL
40.2
305070
Setup ScoreCOOL
1/10
Base depth: 47.5%

Risk Profile

Beta
1.11
52W Vol
77%
ATR
$0.96
Max DD (1Y)
-37%

Volume Analysis

Today
50D Avg
243.5K
Vol Ratio
0.00x
Liquidity
MODERATE

Earnings Momentum

Q2'25
$-1.70
Q3'25
$-1.60
Q4'25-387%
$-5.85
Q1'26+92%
$-0.55
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:-100.00%

Compounded Profit Growth

10 Years:-9.82%
5 Years:
3 Years:
TTM:+11.82%

Stock Price CAGR

10 Years:-19.58%
5 Years:-22.26%
3 Years:-7.30%
1 Year:+73.83%

Return on Equity

10Y Avg:-86.2%
5Y Avg:-91.9%
3Y Avg:-109.8%
Last Year:-130.2%

Key Metrics

Market Cap$948M
Gross Margin
Net Margin
Piotroski F-Score4/9

Frequently Asked Questions

Is DBVT in an uptrend right now?

DBVT has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is DBVT overbought or oversold?

DBVT's RSI (14) is 40. The stock is in neutral territory, neither overbought nor oversold.

Is DBVT outperforming the market?

DBVT has a Relative Strength (RS) Rating of 22 out of 99. DBVT is currently lagging the broader market.

Where is DBVT in its 52-week range?

DBVT is trading at $16.01, which is 61% of its 52-week high ($26.18) and 42% above its 52-week low ($8.51).

How volatile is DBVT?

DBVT has a Beta of 1.11 and 52-week volatility of 77%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.